Olam's Q2 earnings treble to S$94.7m
Factors: fall in minority interests, lower expenses, units' contributions
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
OLAM International's second-quarter earnings have trebled to S$94.7 million despite lower revenue and a net loss from changes in the valuation of biological assets.
The surge in profit attributable to shareholders was helped by a sharp drop in profit attributable to non-controlling interests from $43 million to a negative S$3.9 million. Also helping were lower expenses and its share of profits from joint ventures and associates. The latter came to S$3.9 million, against a negative S$6.7 million a year ago.
Copyright SPH Media. All rights reserved.
TRENDING NOW
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
Near sell-out launches in March boost developer sales to 1,300 units after four slow months
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Genting Singapore’s Lim Kok Thay receives S$7.5 million pay package for FY2025
